343 related articles for article (PubMed ID: 26739825)
1. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
[TBL] [Abstract][Full Text] [Related]
2. PACAP promotes neuron survival in early experimental diabetic retinopathy.
Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
Maugeri G; D'Amico AG; Bucolo C; D'Agata V
Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
[TBL] [Abstract][Full Text] [Related]
5. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
[TBL] [Abstract][Full Text] [Related]
6. Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration.
D'Amico AG; Maugeri G; Rasà DM; Bucolo C; Saccone S; Federico C; Cavallaro S; D'Agata V
Peptides; 2017 Nov; 97():64-69. PubMed ID: 28964802
[TBL] [Abstract][Full Text] [Related]
7. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects.
Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D
Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141
[TBL] [Abstract][Full Text] [Related]
9. Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents.
Werling D; Reglodi D; Banks WA; Salameh TS; Kovacs K; Kvarik T; Vaczy A; Kovacs L; Mayer F; Danyadi B; Lokos E; Tamas A; Toth G; Biro Z; Atlasz T
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6683-6691. PubMed ID: 27936470
[TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats.
Atlasz T; Babai N; Kiss P; Reglodi D; Tamás A; Szabadfi K; Tóth G; Hegyi O; Lubics A; Gábriel R
Gen Comp Endocrinol; 2007; 153(1-3):108-14. PubMed ID: 17289046
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Tamas A; Toth G; Reglodi D; Gabriel R
Brain Res Bull; 2010 Mar; 81(4-5):497-504. PubMed ID: 19751807
[TBL] [Abstract][Full Text] [Related]
12. PACAP Is Protective in a Rat Model of Retinopathy of Prematurity.
Kvarik T; Mammel B; Reglodi D; Kovacs K; Werling D; Bede B; Vaczy A; Fabian E; Toth G; Kiss P; Tamas A; Ertl T; Gyarmati J; Atlasz T
J Mol Neurosci; 2016 Oct; 60(2):179-85. PubMed ID: 27561927
[TBL] [Abstract][Full Text] [Related]
13. Accelerated retinal aging in PACAP knock-out mice.
Kovács-Valasek A; Szabadfi K; Dénes V; Szalontai B; Tamás A; Kiss P; Szabó A; Setalo G; Reglődi D; Gábriel R
Neuroscience; 2017 Apr; 348():1-10. PubMed ID: 28215987
[TBL] [Abstract][Full Text] [Related]
14. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
[TBL] [Abstract][Full Text] [Related]
15. Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.
Tamás A; Gábriel R; Rácz B; Dénes V; Kiss P; Lubics A; Lengvári I; Reglodi D
Neurosci Lett; 2004 Nov; 372(1-2):110-3. PubMed ID: 15531098
[TBL] [Abstract][Full Text] [Related]
16. The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.
Vaczy A; Reglodi D; Somoskeoy T; Kovacs K; Lokos E; Szabo E; Tamas A; Atlasz T
J Mol Neurosci; 2016 Oct; 60(2):186-94. PubMed ID: 27566170
[TBL] [Abstract][Full Text] [Related]
17. Electron microscopic observation of pituitary adenylate cyclase-activating polypeptide (PACAP)-containing neurons in the rat retina.
Seki T; Shioda S; Izumi S; Arimura A; Koide R
Peptides; 2000 Jan; 21(1):109-13. PubMed ID: 10704726
[TBL] [Abstract][Full Text] [Related]
18. Pituitary Adenylate Cyclase-Activating Peptide (PACAP), a Novel Secretagogue, Regulates Secreted Morphogens in Newborn Rat Retina.
Lakk M; Denes V; Kovacs K; Hideg O; Szabo BF; Gabriel R
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):565-572. PubMed ID: 28125843
[TBL] [Abstract][Full Text] [Related]
19. Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion.
Szabo A; Danyadi B; Bognar E; Szabadfi K; Fabian E; Kiss P; Mester L; Manavalan S; Atlasz T; Gabriel R; Toth G; Tamas A; Reglodi D; Kovacs K
Neurosci Lett; 2012 Aug; 523(2):93-8. PubMed ID: 22750211
[TBL] [Abstract][Full Text] [Related]
20. A Promising Combination: PACAP and PARP Inhibitor Have Therapeutic Potential in Models of Diabetic and Hypertensive Retinopathies.
Pöstyéni E; Szabadfi K; Sétáló G; Gabriel R
Cells; 2021 Dec; 10(12):. PubMed ID: 34943979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
